(abb. ISUP: International Society of Urological Pathology)
Table 2: Clinically significant (Gleason ≥ 7) and non-clinically significant (Gleason < 7) prostate cancer distributions accordindg to patient’s PSA, free PSA, PSA density, free / total PSA ratio and prostate volume